FDA and EMA guidance now call for endpoints that capture the full picture of patient well-being, including physical, psychological, and social. If your obesity trials aren't incorporating this multidimensional approach, ...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
A New Horizon
A PharmaTimes article featuring commentary from Tom O’Leary on the future of AI in healthcare. O’Leary discusses how the key to maximising AI’s involvement in pharma development is to utilise its ability to draw distinctions and correlations, which would otherwise elude human observation. However, also notes the potential for AI is most exciting when paired with human experience, creativity and instinct.
